These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 24329732)

  • 1. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.
    Tacconelli E; Cataldo MA; Dancer SJ; De Angelis G; Falcone M; Frank U; Kahlmeter G; Pan A; Petrosillo N; Rodríguez-Baño J; Singh N; Venditti M; Yokoe DS; Cookson B;
    Clin Microbiol Infect; 2014 Jan; 20 Suppl 1():1-55. PubMed ID: 24329732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in definitions and isolation procedures for multidrug-resistant Gram-negative bacteria: a survey of the Society for Healthcare Epidemiology of America Research Network.
    Drees M; Pineles L; Harris AD; Morgan DJ
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):362-6. PubMed ID: 24602940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
    Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
    Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
    Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-Resistant Gram-Negative Bacteria: Infection Prevention and Control Update.
    Mills JP; Marchaim D
    Infect Dis Clin North Am; 2021 Dec; 35(4):969-994. PubMed ID: 34752228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
    Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
    Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collateral benefit of screening patients for methicillin-resistant Staphylococcus aureus at hospital admission: isolation of patients with multidrug-resistant gram-negative bacteria.
    Jones M; Nielson C; Gupta K; Khader K; Evans M
    Am J Infect Control; 2015 Jan; 43(1):31-4. PubMed ID: 25442394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and Control of Multidrug-Resistant Gram-Negative Bacteria in Adult Intensive Care Units: A Systematic Review and Network Meta-analysis.
    Teerawattanapong N; Kengkla K; Dilokthornsakul P; Saokaew S; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S51-S60. PubMed ID: 28475791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of multidrug-resistant Gram-negative bacteria from colonized mothers to their infants: a systematic review and meta-analysis.
    Bulabula ANH; Dramowski A; Mehtar S
    J Hosp Infect; 2020 Jan; 104(1):57-67. PubMed ID: 31604126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline of multidrug-resistant Gram negative infections with the routine use of a multiple decontamination regimen in ICU.
    Camus C; Sauvadet E; Tavenard A; Piau C; Uhel F; Bouju P; Letheulle J; Dollo G; Gacouin A; Lavoué S; Le Tulzo Y
    J Infect; 2016 Sep; 73(3):200-9. PubMed ID: 27373765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of endemic multidrug-resistant Gram-negative bacteria after removal of sinks and implementing a new water-safe policy in an intensive care unit.
    Shaw E; Gavaldà L; Càmara J; Gasull R; Gallego S; Tubau F; Granada RM; Ciercoles P; Dominguez MA; Mañez R; Carratalà J; Pujol M
    J Hosp Infect; 2018 Mar; 98(3):275-281. PubMed ID: 29104124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-level interventions to prevent the acquisition of resistant gram-negative bacteria in critically ill patients: a systematic review.
    Zaky A; Zeliadt SB; Treggiari MM
    Anaesth Intensive Care; 2015 Jan; 43(1):23-33. PubMed ID: 25579286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Rate of Multidrug-Resistant Gram-Negative Bacilli Carriage and Infection in Hospitalized Returning Travelers: A Cross-Sectional Cohort Study.
    Epelboin L; Robert J; Tsyrina-Kouyoumdjian E; Laouira S; Meyssonnier V; Caumes E;
    J Travel Med; 2015; 22(5):292-9. PubMed ID: 25997830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria.
    Avery LM; Nicolau DP
    Expert Opin Investig Drugs; 2018 Apr; 27(4):325-338. PubMed ID: 29611447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology.
    Mattner F; Bange FC; Meyer E; Seifert H; Wichelhaus TA; Chaberny IF
    Dtsch Arztebl Int; 2012 Jan; 109(3):39-45. PubMed ID: 22334820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of sinks and bathing changes to control multidrug-resistant Gram-negative bacteria in a neonatal intensive care unit: a retrospective investigation.
    Tracy M; Ryan L; Samarasekara H; Leroi M; Polkinghorne A; Branley J
    J Hosp Infect; 2020 Apr; 104(4):508-510. PubMed ID: 31982431
    [No Abstract]   [Full Text] [Related]  

  • 17. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?
    Harris AD; McGregor JC; Furuno JP
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S57-61. PubMed ID: 16894516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement.
    ; Guan X; He L; Hu B; Hu J; Huang X; Lai G; Li Y; Liu Y; Ni Y; Qiu H; Shao Z; Shi Y; Wang M; Wang R; Wu D; Xie C; Xu Y; Yang F; Yu K; Yu Y; Zhang J; Zhuo C
    Clin Microbiol Infect; 2016 Mar; 22 Suppl 1():S15-25. PubMed ID: 26627340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in contact precautions to control the nosocomial spread of multi-drug resistant organisms in the endemic setting: a multinational cross-sectional survey.
    Gysin DV; Cookson B; Saenz H; Dettenkofer M; Widmer AF;
    Antimicrob Resist Infect Control; 2018; 7():81. PubMed ID: 30002821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can guidelines for the control of multi-drug-resistant Gram-negative organisms be put into practice? A national survey of guideline compliance and comparison of available guidelines.
    Lynch BL; Schaffer K
    J Hosp Infect; 2019 May; 102(1):1-7. PubMed ID: 30615958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.